124 related articles for article (PubMed ID: 15879442)
1. Hypertension-based clinical risk strategies for detecting microalbuminuria in diabetes.
Baskar V; Kamalakannan D; Kiberd B; Holland MR; Singh BM
QJM; 2005 Jun; 98(6):427-33. PubMed ID: 15879442
[TBL] [Abstract][Full Text] [Related]
2. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
[TBL] [Abstract][Full Text] [Related]
3. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.
McQueen MJ; Gerstein HC; Pogue J; Mann JF; Yusuf S
Am J Kidney Dis; 2006 Dec; 48(6):889-96. PubMed ID: 17162143
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study.
Cotter J; Oliveira P; Cunha P; Polónia J
Nephron Clin Pract; 2009; 113(1):c8-15. PubMed ID: 19590230
[TBL] [Abstract][Full Text] [Related]
5. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic significance of transferrinuria and albumin-specific dipstick testing in primary care patients with elevated office blood pressure.
Zeller A; Haehner T; Battegay E; Martina B
J Hum Hypertens; 2005 Mar; 19(3):205-9. PubMed ID: 15549141
[TBL] [Abstract][Full Text] [Related]
7. True resistant hypertension: is it possible to be recognized in the office?
Muxfeldt ES; Bloch KV; Nogueira Ada R; Salles GF
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1534-40. PubMed ID: 16364821
[TBL] [Abstract][Full Text] [Related]
8. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
Agha A; Bashir K; Anwar E
Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
[TBL] [Abstract][Full Text] [Related]
9. Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy.
Ngarmukos C; Bunnag P; Kosachunhanun N; Krittiyawong S; Leelawatana R; Prathipanawatr T; Plengvidhya N; Benjasuratwong Y; Suwanwalaikorn S; Deerochanawong C; Chetthakul T; Mongkolsomlit S; Rawdaree P
J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S37-42. PubMed ID: 17715832
[TBL] [Abstract][Full Text] [Related]
10. Utility of the Dipstick Micraltest II in the screening of microalbuminuria of diabetes mellitus type 2 and essential hypertension.
Cortés-Sanabria L; Martínez-Ramírez HR; Hernández JL; Rojas-Campos E; Canales-Muñoz JL; Cueto-Manzano AM
Rev Invest Clin; 2006; 58(3):190-7. PubMed ID: 16958293
[TBL] [Abstract][Full Text] [Related]
11. Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk? The HUNT Study, Norway.
Kvenild K; Romundstad S; Midthjell K; Krüger O; Hallan H; Holmen J
Scand J Prim Health Care; 2006 Sep; 24(3):145-53. PubMed ID: 16923623
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tests for microalbuminuria screening in patients with diabetes.
Incerti J; Zelmanovitz T; Camargo JL; Gross JL; de Azevedo MJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2402-7. PubMed ID: 16105865
[TBL] [Abstract][Full Text] [Related]
13. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
Buranakitjaroen P; Deerochanawong C; Bunnag P
J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
[TBL] [Abstract][Full Text] [Related]
14. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
15. Diabetic nephropathy: common questions.
Thorp ML
Am Fam Physician; 2005 Jul; 72(1):96-9. PubMed ID: 16035688
[TBL] [Abstract][Full Text] [Related]
16. The use of semi-quantitative urine test-strip (Micral Test) for microalbuminuria screening in patients with diabetes mellitus.
Leong SO; Lui KF; Ng WY; Thai AC
Singapore Med J; 1998 Mar; 39(3):101-3. PubMed ID: 9632966
[TBL] [Abstract][Full Text] [Related]
17. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
Muxfeldt ES; Salles GF
J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
[TBL] [Abstract][Full Text] [Related]
18. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of microalbuminuria in non-diabetic hypertensive patients attended by Portuguese GPs.
Polónia J; Carmona J; Mendes E; Pisco L
Rev Port Cardiol; 2007 Jun; 26(6):637-44. PubMed ID: 17849947
[TBL] [Abstract][Full Text] [Related]
20. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
Azizi M; Ménard J; Peyrard S; Lièvre M; Marre M; Chatellier G
Diabetes Care; 2006 Jun; 29(6):1331-6. PubMed ID: 16732017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
